NELSON HANDAL: Open Payments
NPI 1154471548 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,970 in 91 payments from 15 companies in 2025. Trend: 2023 $25,917 · 2024 $9,235 · 2025 $3,970
Food & beverage: $1,990Consulting: $1,980
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $2,172 |
| Vanda Pharmaceuticals Inc. | 19 | $573 |
| ABBVIE INC. | 14 | $261 |
| Corium, LLC | 11 | $226 |
| Janssen Pharmaceuticals, Inc | 8 | $156 |
| Axsome Therapeutics, Inc. | 5 | $122 |
| Otsuka America Pharmaceutical, Inc. | 6 | $107 |
| Almatica Pharma LLC | 4 | $100 |
| Alkermes, Inc. | 4 | $91 |
| Tris Pharma Inc | 4 | $62 |
Products named: CAPLYTA, FANAPT, VRAYLAR, Azstarys, LOREEV XR, INVEGA SUSTENNA, Auvelity, REXULTI.
Industry payments across AL — which companies pay providers there.
